Strategic approach to pharmaceuticals in the environment

This procedure focuses on developing a coordinated strategy to reduce the environmental impact of pharmaceutical products. It aims to address the presence of medicinal residues in water and soil, ensuring that the benefits of medicine do not come at the cost of ecosystem health and water quality.

This will affect pharmaceutical manufacturers, healthcare providers, and waste management sectors by introducing stricter guidelines for the production, use, and disposal of medicines.